drug · small molecule
patient view →LB-100
Phase 2updated 2mo agoby $LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC.🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Phase 2 (across all indications), with 6 investigational indications.
targets
Serine/threonine-protein phosphatase 5Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoformSerine/threonine-protein phosphatase 2A catalytic subunit beta isoform
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that